DIAGNOSTIC DEALS

Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month

The pace of diagnostic deal making picked up from the end of March through mid-April. Here's a quick overview of the activity and key deals made during the period. Mergers & Acquisitions and … [Read more...]

NEW PRODUCTS

The Dx Pipeline: A Roundup of the Month’s Key New Product Launches

Qiagen was the most active firm of the period with a trio of new product launches, including the US launch of Therascreen FGFR RGQ RT-PCR Kit as a companion diagnostic for Janssen Pharmaceutical's … [Read more...]

INDUSTRY BUZZ

FDA Watch: New Warning Letter May Signal Resurgence of LDT Enforcement Activity

After a couple of years of dormancy, the FDA laboratory developed test (LDT) enforcement volcano stirred on April 4, when the agency issued a warning letter to Inova Genomics Laboratory (Inova) for … [Read more...]

NEW PRODUCTS

The Dx Pipeline: A Roundup of the Month’s Key New Product Launches

March was the most intense month of the year so far for new diagnostic products highlighted by 23andMe's launch of a new genetic Health Predisposition report assessing a consumer's risks of developing … [Read more...]

INDUSTRY BUZZ

FDA Watch: Gottlieb Resignation Costs Lab Industry a Valuable Frenemy

Scott Gottlieb, M.D., is resigning as FDA commissioner, the position he's held since 2017. Although his reign lasted just two years, Gottlieb has been a longtime friend and foe of the lab industry … [Read more...]

DIAGNOSTIC DEALS

Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month

Spring has sprung with the announcement of a king-size deal: Danaher's $21.4 billion cash acquisition of GE Life Sciences, known as GE Biopharma, from General Electric Company (GE). Here's a quick … [Read more...]

DIAGNOSTIC DEALS

Diagnostic Deals: A Roundup of the Key Mergers, Acquisitions, Alliances, Licenses and Other Strategic Transactions From the Past Month

The past few weeks have brought snow to parts of the country that don't usually see the white stuff, and a flurry of diagnostic deals. Although some pundits continue to speculate about a business … [Read more...]

NEW PRODUCTS

The Dx Pipeline: A Roundup of the Month’s Key New Product Launches

After a slow January, new product development picked up steam in February. Here's a rundown of the key new launches. NEWLY LAUNCHED PRODUCTS & … [Read more...]

INDUSTRY BUZZ

FDA Watch: Agency Finalizes New Medical Device Marketing Pathway & Okays Direct Lab Reporting of PGx Test Results

On Jan. 22, the FDA issued final guidance establishing a new alternative pathway for getting medical devices to market. Under the "Safety and Performance Based Pathway" (new Pathway), new product … [Read more...]

NEW PRODUCTS

The Dx Pipeline: A Roundup of the Month’s Key New Product Launches

Late December through January was fairly slow for new product launches in terms of both volume and impactful-ness. Here's a rundown of the new offerings that did emerge from the pipeline: NEWLY … [Read more...]


(-00000g2)